Latest Breaking News On - Abrdn life sciences investors - Page 2 : vimarsana.com

Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) major shareholder Saba Capital Management, L.P. purchased 16,573 shares of the business’s stock in a transaction on Tuesday, April 30th. The stock was purchased at an average cost of $13.13 per share, with a total value of $217,603.49. Following the acquisition, the insider now owns 3,042,204 […]

Abrdn life sciences investors company profileKingsview wealth managementAbrdn life sciences investorsAbrdn life sciences investors increases dividendJanney montgomery scottFinancial wealth managmentBlue bell private wealth managementShaker financial servicesAbrdn life sciences investors tradingQuarter for abrdn life sciences investorsGet free reportSaba capital managementCapital managementLife sciences investorsWealth managementMontgomery scott